Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): Restoration of ovulatory function and fertility
- 1 September 1973
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 117 (1) , 75-79
- https://doi.org/10.1016/0002-9378(73)90731-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)Journal of Clinical Endocrinology & Metabolism, 1972
- Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptineBMJ, 1972
- Antagonism of 2-Br-α-ergokryptine-methanesulfonate (CB 154) to certain endocrine actions of centrally active drugsCellular and Molecular Life Sciences, 1972
- Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind StudyBMJ, 1972
- Treatment of Non-puerperal Galactorrhoea with an Ergot AlkaloidBMJ, 1971
- Post-pill and pill-related amenorrhea-galactorrheaAmerican Journal of Obstetrics and Gynecology, 1971
- Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-α-ergokryptine (CB 154)Cellular and Molecular Life Sciences, 1971
- Secondary amenorrhea with inappropriate lactationAmerican Journal of Obstetrics and Gynecology, 1970
- 2-Br-α-Ergokryptin: Beeinflussung von Fertilität und Laktation bei der RatteCellular and Molecular Life Sciences, 1968
- Chiari-Frommel syndromeAmerican Journal of Obstetrics and Gynecology, 1964